Alkyl Amines Chemicals Ltd
Incorporated in 1979 by Mr Yogesh Kothari, Alkyl Amines is a leading manufacturer of aliphatic amines in India. Aliphatic amines are products derived from Ammonia (NH3) by displacement of H2 in the Ammonia molecule by other radicals (R) such as Methyl, Ethyl and Propyl.
- Market Cap ₹ 9,778 Cr.
- Current Price ₹ 1,912
- High / Low ₹ 2,400 / 1,212
- Stock P/E 51.6
- Book Value ₹ 105
- Dividend Yield 0.52 %
- ROCE 41.3 %
- ROE 41.4 %
- Face Value ₹ 2.00
Pros
- Company has reduced debt.
- Company has delivered good profit growth of 33.3% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 31.6%
- Company has been maintaining a healthy dividend payout of 20.3%
Cons
- Stock is trading at 18.6 times its book value
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 197 | 214 | 236 | 288 | 366 | 446 | 476 | 484 | 501 | 616 | 846 | 993 | |
| 175 | 183 | 205 | 245 | 308 | 361 | 390 | 393 | 405 | 499 | 682 | 736 | |
| Operating Profit | 21 | 32 | 31 | 42 | 58 | 85 | 87 | 91 | 95 | 118 | 164 | 257 |
| OPM % | 11% | 15% | 13% | 15% | 16% | 19% | 18% | 19% | 19% | 19% | 19% | 26% |
| 6 | 6 | 2 | 3 | 1 | 2 | 2 | 3 | 3 | 4 | 6 | 26 | |
| Interest | 12 | 12 | 10 | 12 | 13 | 12 | 10 | 8 | 8 | 8 | 15 | 10 |
| Depreciation | 7 | 9 | 9 | 9 | 10 | 10 | 11 | 13 | 14 | 16 | 23 | 27 |
| Profit before tax | 8 | 18 | 14 | 24 | 36 | 65 | 67 | 73 | 75 | 97 | 133 | 246 |
| Tax % | 33% | 28% | 24% | 27% | 33% | 33% | 32% | 31% | 31% | 32% | 35% | 18% |
| 6 | 13 | 14 | 18 | 24 | 43 | 45 | 50 | 52 | 66 | 86 | 201 | |
| EPS in Rs | 1.10 | 2.51 | 2.74 | 3.45 | 4.75 | 8.48 | 8.85 | 9.81 | 10.16 | 12.94 | 16.88 | 39.47 |
| Dividend Payout % | 36% | 24% | 22% | 23% | 21% | 19% | 18% | 41% | 20% | 22% | 19% | 20% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 16% |
| 3 Years: | 26% |
| TTM: | 17% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 31% |
| 5 Years: | 33% |
| 3 Years: | 54% |
| TTM: | 120% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 29% |
| 5 Years: | -12% |
| 3 Years: | -7% |
| 1 Year: | -12% |
| Return on Equity | |
|---|---|
| 10 Years: | 28% |
| 5 Years: | 29% |
| 3 Years: | 32% |
| Last Year: | 41% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Reserves | 56 | 64 | 75 | 88 | 106 | 140 | 174 | 199 | 246 | 299 | 369 | 526 |
| 133 | 114 | 120 | 123 | 146 | 151 | 135 | 111 | 120 | 181 | 165 | 87 | |
| 54 | 51 | 52 | 60 | 78 | 98 | 93 | 95 | 147 | 159 | 218 | 160 | |
| Total Liabilities | 254 | 238 | 258 | 282 | 341 | 398 | 412 | 416 | 522 | 649 | 763 | 783 |
| 103 | 98 | 98 | 122 | 126 | 155 | 151 | 187 | 220 | 355 | 376 | 423 | |
| CWIP | 7 | 14 | 23 | 6 | 9 | 3 | 31 | 16 | 35 | 18 | 43 | 45 |
| Investments | 4 | 6 | 10 | 10 | 10 | 10 | 10 | 10 | 12 | 13 | 16 | 0 |
| 139 | 121 | 126 | 144 | 195 | 230 | 220 | 203 | 256 | 262 | 328 | 315 | |
| Total Assets | 254 | 238 | 258 | 282 | 341 | 398 | 412 | 416 | 522 | 649 | 763 | 783 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 22 | 43 | 24 | 36 | 22 | 47 | 61 | 101 | 63 | 102 | 144 | 188 | |
| -22 | -10 | -17 | -19 | -27 | -27 | -31 | -35 | -65 | -132 | -67 | -41 | |
| 3 | -35 | -9 | -13 | 5 | -13 | -36 | -68 | -2 | 32 | -60 | -135 | |
| Net Cash Flow | 3 | -2 | -2 | 4 | 0 | 7 | -6 | -2 | -3 | 2 | 17 | 12 |
| Free Cash Flow | -1 | 33 | 6 | 21 | -2 | 21 | 20 | 66 | -1 | -33 | 75 | 111 |
| CFO/OP | 122% | 154% | 86% | 101% | 54% | 55% | 95% | 128% | 88% | 103% | 109% | 96% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 70 | 66 | 73 | 77 | 76 | 73 | 76 | 68 | 71 | 73 | 66 | 60 |
| Inventory Days | 261 | 180 | 166 | 124 | 132 | 126 | 105 | 92 | 165 | 99 | 88 | 67 |
| Days Payable | 1 | 0 | 70 | 63 | 69 | 75 | 58 | 63 | 120 | 78 | 104 | 57 |
| Cash Conversion Cycle | 329 | 246 | 170 | 137 | 139 | 124 | 123 | 96 | 116 | 94 | 51 | 71 |
| Working Capital Days | 182 | 142 | 15 | 10 | 20 | 96 | 93 | 87 | 84 | 76 | 56 | 54 |
| ROCE % | 11% | 15% | 12% | 17% | 20% | 28% | 25% | 25% | 24% | 25% | 28% | 41% |
Insights
In beta| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Export Value (FOB) Rs Lakhs ・Standalone data |
|
||||||||||
| R&D Expenditure (% of Turnover) % ・Standalone data |
|||||||||||
| Total Permanent Employees count ・Standalone data |
|||||||||||
| Revenue Mix - Aliphatic Amines (% of Revenue) % ・Standalone data |
|||||||||||
| Revenue Mix - Amine Derivatives (% of Revenue) % ・Standalone data |
|||||||||||
| Revenue Mix - Specialty Chemicals (% of Revenue) % ・Standalone data |
|||||||||||
| International Presence (Countries Exported To) count ・Standalone data |
|||||||||||
| Total Sales Volume tons ・Standalone data |
|||||||||||
| Installed Capacity by Site TPA ・Standalone data |
|||||||||||
| Overall Capacity Utilization % ・Standalone data |
|||||||||||
| R&D Expenditure (Percentage of Turnover) % ・Standalone data |
|||||||||||
Extracted by Screener AI
Documents
Announcements
- Shareholder Meeting / Postal Ballot-Scrutinizer''s Report 7 Jul
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 7 Jul
-
Shareholder Meeting / Postal Ballot-Outcome of AGM
3 Jul - 46th AGM held; Rs10 dividend approved; anti-dumping duty on acetonitrile approved.
- Closure of Trading Window 24 Jun
- Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS 16 Jun
Annual reports
-
Financial Year 2026
from bse
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
Concalls
-
May 2026TranscriptPPT
-
Nov 2025TranscriptPPTREC
-
May 2025TranscriptPPT
-
Nov 2024TranscriptPPT
-
May 2024Transcript PPT REC
-
May 2024TranscriptPPTREC
-
Nov 2023TranscriptPPTREC
-
May 2023TranscriptPPT
-
Nov 2022TranscriptPPT
-
May 2022TranscriptPPT
-
Nov 2021TranscriptPPT
-
Jun 2021TranscriptPPT
-
Nov 2020TranscriptPPT
-
Jul 2020TranscriptPPT
-
Nov 2019TranscriptPPT
-
May 2019TranscriptPPT
-
Nov 2018TranscriptPPT
-
Jun 2018TranscriptPPT
-
Nov 2017TranscriptPPT
-
Jun 2017TranscriptPPT
-
May 2016TranscriptPPT
Market Leadership[1] [2]
The company is a global supplier of aliphatic amines, specialty amines, and amine derivatives to the pharmaceutical, agrochemical, water treatment, rubber chemical, and a variety of industries. It holds a leadership position in some of the products in the domestic market.